Caring Brands (CABR) EBIT Margin (2024 - 2025)
Caring Brands' (CABR) quarterly EBIT Margin came in at 235600.5% in Q4 2025, down 4789706.0% year-on-year from N/an in Q4 2024, and down 74.44% quarter-over-quarter from 135064.19% in Q3 2025.
Caring Brands (CABR) EBIT Margin (2024 - 2025) Analysis & Trends
Caring Brands' EBIT Margin history runs 2 years deep, the most recent figure standing at 235600.5% for Q4 2025.
- On a quarterly basis, EBIT Margin fell 4789706.0% year-over-year to 235600.5% in Q4 2025; TTM through Dec 2025 was 144325.42%, a N/A change from a year earlier, with the FY2025 full-year figure at 140807.24%, changed N/A from the prior year.
- EBIT Margin declined to 235600.5% in Q4 2025 per CABR's latest filing, from 135064.19% in the prior quarter.
- Across five years, EBIT Margin topped out at 36714.98% in Q1 2025 and bottomed at 235600.5% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Caring Brands | 20.08 Mn | 21.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -235,600.50% |
| Sep 30, 2025 | -135,064.19% |
| Mar 31, 2025 | -36,714.98% |
| Dec 31, 2024 | -187,703.44% |